Clinical and oncological outcomes after surgical excision of pigmented villonodular synovitis at the foot and ankle

Foot and Ankle Surgery

Volumn 20, Issue 2, 2014, Pages 130-134

  Korim, M T ^a   Clarke, D R ^a   Allen, P E ^a   Richards, C J ^b,c   Ashford, R U ^a,b,d  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b Infirmary Square   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Diffuse PVNS; Foot and ankle; Outcome scores; Pigmented villonodular synovitis; Recurrence; Surgical excision

Indexed keywords

ADULT; AMERICAN ACADEMY OF FOOD AND ANKLE SURGEON SCORE; ANKLE ARTHRITIS; ANKLE ARTHRODESIS; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOOT AND ANKLE PIGMENTED VILLONODULAR SYNOVITIS; FOOT DISEASE; FOREFOOT; HISTOPATHOLOGY; HUMAN; MALE; METATARSAL OSTEOTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PIGMENTED VILLONODULAR SYNOVITIS; PRIORITY JOURNAL; RATING SCALE; RECURRENCE RISK; SCORING SYSTEM; SYNOVECTOMY; TORONTO EXTREMITY SALVAGE SCORE; UNITED KINGDOM; UNIVERSITY HOSPITAL; ANKLE; COMPLICATION; FACTUAL DATABASE; FOOT; MIDDLE AGED; PATHOLOGY; SYNOVITIS, PIGMENTED VILLONODULAR; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANKLE JOINT; DATABASES, FACTUAL; FEMALE; FOOT JOINTS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; SYNOVITIS, PIGMENTED VILLONODULAR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899989731     PISSN: 12687731     EISSN: 14609584     Source Type: Journal    
DOI: 10.1016/j.fas.2014.01.007     Document Type: Article

References (20)

1. Van der Heijden L., Gibbons C.L.M.H., Dijkstra P.D.S., Kroep J.R., van Rijswijk C.S.P., Nout R.A., et al. The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis). J Bone Joint Surg Br 2012, 94:882-888.
2. Stevenson J.D., Jaiswal A., Gregory J.J., Mangham D.C., Cribb G.C.P. Diffuse pigmented villonodular synovitis (diffuse-type giant cell tumour) of the foot and ankle. Bone Joint J 2013, 95B:384-390.
3. Jaffe H.L., Lichenstein L.S.C. Pigmented villonodular synovitis, bursitis and tenosynovitis: a discussion of the synovial and bursal equivalents of the tenosynovial lesion commonly denoted as xanthoma, xanthogranuloma, giant cell tumor, or myeloplaxoma of the tendon sheath lesion itsel. Arch Pathol 1941, 31:731-765.
4. Granowitz S.P., Mankin H.J. Localized pigmented villonodular synovitis of the knee. Report of five cases. J Bone Joint Surg Am 1967, 49:122-128.
5. Stevenson J.D., Cribb G.C.P. Pigmented villonodular synovitis of the joints and tendon sheaths. Orthop Trauma 2012, 26:273-279.
6. Tyler W.K., Vidal A.F., Williams R.J., Healey J.H. Pigmented villonodular synovitis. J Am Acad Orthop Surg 2006, 14:376-385.
7. Lee M., Mahroof S., Pringle J., Short S.C., Briggs T.W.R., Cannon S.R. Diffuse pigmented villonodular synovitis of the foot and ankle treated with surgery and radiotherapy. Int Orthop 2005, 29:403-405.
8. Bisbinas I., De Silva U., Grimer R.J. Pigmented villonodular synovitis of the foot and ankle: a 12-year experience from a tertiary orthopedic Oncology Unit. J Foot Ankle Surg 2004, 43:407-411.
9. Shabat S., Kollender Y., Merimsky O., Isakov J., Flusser G., Nyska M., et al. The use of surgery and yttrium 90 in the management of extensive and diffuse pigmented villonodular synovitis of large joints. Rheumatology (Oxford) 2002, 41:1113-1118.
10. Bickels J., Isaakov J., Kollender Y., Meller I. Unacceptable complications following intra-articular injection of yttrium 90 in the ankle joint for diffuse pigmented villonodular synovitis. J Bone Joint Surg Am 2008, 90:326-328.
11. Rochwerger A., Groulier P., Curvale G., Launay F. Pigmented villonodular synovitis of the foot and ankle: a report of eight cases. Foot Ankle Int 1999, 20:587-590.
12. Davis A.M., Bell R.S., Badley E.M., Yoshida K., Williams J.I. Evaluating functional outcome in patients with lower extremity sarcoma. Clin Orthop Relat Res 1999, 90-100.
13. Johanson N.A., Liang M.H., Daltroy L., Rudicel S., Richmond J. American Academy of Orthopaedic Surgeons lower limb outcomes assessment instruments, reliability, validity, and sensitivity to change. J Bone Joint Surg Am 2004, 86A:902-909.
14. Myers B.W., Masi A.T. Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review. Medicine (Baltimore) 1980, 59:223-238.
15. Rao A.S., Vigorita V.J. Pigmented villonodular synovitis (giant-cell tumor of the tendon sheath and synovial membrane). A review of eighty-one cases. J Bone Joint Surg Am 1984, 66:76-94.
16. Ghert M.A., Scully S.P., Harrelson J.M. Pigmented villonodular synovitis of the foot and ankle: a review of six cases. Foot Ankle Int 1999, 20:326-330.
17. Sharma H., Jane M.J., Reid R. Pigmented villonodular synovitis of the foot and ankle: forty years of experience from the Scottish bone tumor registry. J Foot Ankle Surg 2006, 45:329-336.
18. Saxena A., Perez H. Pigmented villonodular synovitis about the ankle: a review of the literature and presentation in 10 athletic patients. Foot Ankle Int 2004, 25:819-826.
19. Brien E.W., Sacoman D.M., Mirra J.M. Pigmented villonodular synovitis of the foot and ankle. Foot Ankle Int 2004, 25:908-913.
20. Cassier P.A., Gelderblom H., Stacchiotti S., Thomas D., Maki R.G., Kroep J.R., et al. Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis. Cancer 2012, 118:1649-1655.